Beijing Cancer hospital ( Site 0715)

Beijing, Beijing Municipality 100142

0 studies enrolling now · 1 studies all time

What they study most

Endometrial Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15) — Running, not enrolling